{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)", "item": "https://www.patentleaderboard.com/patent/11345741"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

US Patent 11345741 · Granted May 31, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide vaccine based on a new universal influenza a hemagglutinin head domain e2025
Human monoclonal antibodies to enterovirus D682025
Human monoclonal antibodies to a new universal influenza A hemagglutinin head do2025
Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C viru2025
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (2025
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (2025
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (2025
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (2025
Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses2025
Human monoclonal antibodies against yellow fever virus and uses therefor2024
Human West Nile virus antibodies and methods of use therefor2024
Human monoclonal antibodies to Staphylococcal aureus Isd proteins and uses there2024